INS and Hypoglycemia: Although CGM metrics for hypoglycemia (TBR) are increasingly used inclinical practice and collected in most phase 3 once-weekly insulin studies, they arecurrently not accepted by regulators or guidelines as a means to compare hypoglycemia rates.However, recent draft guidance from the US Food and Drug Administration (FDA), if approved,may affect these limitations (169).